Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(28), P. 10810 - 10822
Published: Jan. 1, 2024
Development
of
substrate-selective
nanozyme
requires
careful
attention.
We
show
that
proteins
with
dimensions
larger
than
the
pore
aperture
MOF-808,
installed
a
bis-(μ-oxo)
dicopper
active
site
in
its
adamantane
pore,
can
compromise
substrate
selectivity
oxidase
nanozyme.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(26), P. 16450 - 16467
Published: June 19, 2024
Nanozymes,
which
can
selectively
scavenge
reactive
oxygen
species
(ROS),
have
recently
emerged
as
promising
candidates
for
treating
ischemic
stroke
and
traumatic
brain
injury
(TBI)
in
preclinical
models.
ROS
overproduction
during
the
early
phase
of
these
diseases
leads
to
oxidative
damage,
has
been
a
major
cause
mortality
worldwide.
However,
clinical
application
ROS-scavenging
enzymes
is
limited
by
their
short
vivo
half-life
inability
cross
blood-brain
barrier.
mimic
catalytic
function
natural
enzymes,
several
advantages,
including
cost-effectiveness,
high
stability,
easy
storage.
These
advantages
render
them
superior
disease
diagnosis
therapeutic
interventions.
This
review
highlights
recent
advancements
nanozyme
applications
TBI,
emphasizing
potential
mitigate
detrimental
effect
overproduction,
inflammation,
barrier
compromise.
Therefore,
nanozymes
represent
treatment
modality
conditions
future
medical
practices.
Small,
Journal Year:
2024,
Volume and Issue:
20(34)
Published: April 15, 2024
Abstract
CeO
2
,
particularly
in
the
shape
of
rod,
has
recently
gained
considerable
attention
for
its
ability
to
mimic
peroxidase
(POD)
and
haloperoxidase
(HPO).
However,
this
multi‐enzyme
activities
unavoidably
compete
H
O
affecting
performance
relevant
applications.
The
lack
consensus
on
facet
distribution
rod‐shaped
further
complicates
establishment
structure‐activity
correlations,
presenting
challenges
progress
field.
In
study,
HPO‐like
activity
is
successfully
enhanced
while
maintaining
POD‐like
through
a
facile
post‐calcination
method.
By
studying
spatial
these
two
their
exclusive
activation
pathways
surfaces,
study
finds
that
increased
originated
from
newly
exposed
(111)
surface
at
tip
shortened
rods
after
calcination,
unchanged
attributed
retained
(110)
lateral
area.
These
findings
not
only
address
discrepancies
commonly
reported
literature
but
also
offer
simple
approach
enhance
antibacterial
performance.
This
work
expected
provide
atomic
insights
into
catalytic
correlations
guide
design
nanozymes
with
improved
reaction
specificity.
Langmuir,
Journal Year:
2024,
Volume and Issue:
40(24), P. 12671 - 12680
Published: June 10, 2024
The
design
of
single-atom
nanozymes
with
dual
active
sites
to
increase
their
activity
and
for
the
detection
degradation
contaminants
is
rare
challenging.
In
this
work,
a
nanozyme
(FeCu-NC)
based
on
three-dimensional
porous
Fe/Cu
site
was
developed
as
colorimetric
sensor
both
quantitative
analysis
isoniazid
(INH)
efficient
levofloxacin
(LEV).
FeCu-NC
synthesized
using
salt
template
freeze-drying
method
hollow
structure
(Fe–Nx
Cu–Nx).
terms
morphology
structure,
exhibits
excellent
peroxidase-like
catalytic
properties.
Therefore,
constructed
around
sensitive
rapid
INH
linear
range
0.9–10
μM
limit
low
0.3
μM,
successfully
applied
in
human
urine.
addition,
promoted
LEV
by
peroxymonosulfate
activation,
rate
90.4%
at
30
min.
This
work
sheds
new
light
application
antibiotics
sensing
degradation.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(35), P. 24162 - 24172
Published: Aug. 20, 2024
Although
the
past
decade
has
witnessed
a
rapid
development
of
oxidoreductase-mimicking
nanozymes,
mimicry
cofactors
that
play
key
roles
in
mediating
electron
and
proton
transfer
remains
limited.
This
study
explores
how
surface
Au-H
species
conjugated
to
Au
nanoparticles
(NPs)
imitate
formate
dehydrogenase
(FDH)
can
serve
as
cofactors,
analogous
NADH
natural
enzymes,
offering
diverse
possibilities
for
FDH-mimicking
nanozymes
mimic
various
enzymes.
Once
O
Nano Letters,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 17, 2025
Atherosclerosis,
resulting
from
chronic
inflammation
of
the
arterial
wall,
serves
as
underlying
cause
multiple
major
cardiovascular
diseases.
Current
anti-inflammatory
therapies
often
exhibit
limited
and
unsatisfactory
efficacy.
To
address
this,
we
have
designed
a
selenium-doped
copper
formate
(Cuf-Se)
nanozyme
for
treatment
atherosclerosis,
which
possesses
superoxide
dismutase
(SOD)
glutathione
peroxidase
(GPx)-like
activities.
The
Cuf-Se
can
efficiently
scavenge
reactive
oxygen
species
(ROS),
inhibit
cellular
senescence,
prevent
formation
foam
cells.
It
acts
on
macrophages
to
reduce
ROS
levels
lipid
oxidation,
thereby
significantly
inhibiting
inflammation-related
processes.
Notably,
while
cell
formation,
also
alleviates
endothelial
cells
senescence.
After
intravenous
administration,
effectively
inhibits
atherosclerosis
in
mice
through
synergistic
effects
antisenescence
antioxidant
properties,
reducing
plaque
area
by
approximately
5-fold.
This
study
provides
an
effective
strategy
atherosclerosis.